Hypertrophic cardiomyopathy (HCM)
- Treat symptoms and sudden-death risk separately
- Beta blocker first for many symptomatic patients
- Non-DHP CCB if beta blocker unsuitable
- Obstructive disease may use myosin inhibitor
- ICD based on arrhythmic risk—not symptom severity
- Refer severe obstruction for septal-reduction evaluation
Use at a glance
- Treat symptoms and sudden-death risk separately
Practical pearls
- Beta blocker first for many symptomatic patients
- Obstructive disease may use myosin inhibitor
Choosing treatment
- Non-DHP CCB if beta blocker unsuitable
- Refer severe obstruction for septal-reduction evaluation
Other practical pearls
- ICD based on arrhythmic risk—not symptom severity
Self-check
- What determines ICD use in HCM?
Arrhythmic risk, not symptom severity. - What is first for many symptomatic HCM patients?
A beta blocker.
Drugs used for this (2)
All clinical uses · Open Hypertrophic cardiomyopathy (HCM) in the interactive console ↗